PPARG and cancer: In search of cancer cell growth inhibitors downstream circadian controlled pathways, ligands of PPARG (peroxisome proliferator activated receptor gamma) showed to be reducing tumor aggressiveness and enhancing cytotoxic action of anti-cancer agents (238, 239).